A Study to Learn About a Combined Injection for COVID-19 and Flu in Healthy Adults
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older
Category & Conditions: Coronavirus Disease (COVID-19)
Medicine: PF-08044562
ClinicalTrials.gov Identifier (NCT): NCT06237049
Protocol ID: C5681001
Open Plain Language Summary Result:
Click here